Early IV-injected human dermis-derived mesenchymal stem cells after transient global cerebral ischemia do not pass through damaged blood-brain barrier

Author:

Ahn Ji Hyeon1,Chen Bai Hui2,Park Joon Ha1,Shin Bich Na3,Lee Tae-Kyeong3,Cho Jeong Hwi3,Lee Jae Chul3,Park Jeong-Ran4,Yang Se-Ran4,Ryoo Sungwoo5,Shin Myoung Cheol6,Cho Jun Hwi6,Kang Il Jun7,Lee Choong Hyun8,Hwang In Koo9,Kim Young-Myeong10,Won Moo-Ho3ORCID

Affiliation:

1. Department of Biomedical Science and Research Institute for Bioscience and Biotechnology; Hallym University; Chuncheon Gangwon Republic of Korea

2. Department of Histology and Embryology, Institute of Neuroscience; Wenzhou Medical University; Wenzhou Zhejiang China

3. Department of Neurobiology, and Institute of Medical Sciences, School of Medicine; Kangwon National University; Chuncheon Gangwon Republic of Korea

4. Department of Thoracic and Cardiovascular Surgery, School of Medicine, and Stem Cell Institute; Kangwon National University; Chuncheon Gangwon Republic of Korea

5. Department of Biological Sciences, College of Natural Sciences; Kangwon National University; Chuncheon Gangwon Republic of Korea

6. Department of Emergency Medicine, School of Medicine; Kangwon National University; Chuncheon Gangwon Republic of Korea

7. Department of Food Science and Nutrition; Hallym University; Chuncheon Gangwon Republic of Korea

8. Department of Pharmacy, College of Pharmacy; Dankook University; Cheonan Chungcheongnam Republic of Korea

9. Department of Anatomy and Cell Biology, College of Veterinary Medicine, and Research Institute for Veterinary Science; Seoul National University; Seoul Republic of Korea

10. Department of Molecular and Cellular Biochemistry, School of Medicine; Kangwon National University; Chuncheon Gangwon Republic of Korea

Funder

National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology

Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP

National Research Foundation of Korea, which was funded by the Ministry of Science, ICT, and Future Planning

Publisher

Wiley

Subject

Biomedical Engineering,Biomaterials,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3